))
A New Day for HIV Treatment
Manage episode 340311025 series 3383148
Kandungan disediakan oleh American Academy of HIV Medicine. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh American Academy of HIV Medicine atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Academy Executive Director, Bruce Packett, is joined by clinical HIV Pharmacist™ Dr. Brooke Stevens to discuss new and novel antiretroviral therapies including single pill regimens and long-acting injectables. These new regimens allow antiretroviral therapy to be administered less frequently, making it potentially easier for patients to remain adherent.
They discuss who might be good candidates to consider switching to novel formulations and modalities, as well as trends in which patients are interested in switching. But there are some barriers to uptake of these novel treatments, including prior authorization requirements and challenges with rolling out new therapies.
About Dr. Stevens:
Dr. Brooke Stevens is the specialty pharmacy clinical manager at Indiana University Health in Indianapolis, Indiana and a clinical pharmacist at LifeCare Clinic at Methodist Hospital as well as the Ryan White Center for Pediatric Infectious Disease and Global Health at Riley Hospital for Children at Indiana University Health.
********
Questions about this topic? E-mail podcast@aahivm.org to get connected with Bruce or any of our guests.
Are you a medical provider and want to join the conversation? Make your voice heard in the Academy Communities and connect with other HIV clinicians!
To learn more about the Academy, visit www.aahivm.org
12 episod
Kongsi
